Shamburg News · 8-K filed Nov 10, 2026, 5:20 PM EST
Rallybio Announces One-for-Two Reverse Stock Split Tied to Proposed Avenzo Merger
RLYB · Rallybio Corp
- Other event
- Acquisition
- Shareholder vote
- Materiality: medium
Rallybio Corporation announced a one-for-two reverse stock split of its common stock in connection with its Merger Agreement with Avenzo Therapeutics, Inc., dated May 31, 2026. The split is expected to become effective at 12:01 a.m. Eastern Time on November 20, 2026, reducing outstanding shares from approximately 5.6 million to approximately 2.8 million before the Merger closes. Stockholders approved a reverse split ratio range of one-for-two to one-for-nine at the November 4, 2026 Annual Meeting, and fractional shares will be settled in cash.
Source: SEC EDGAR, Form 8-K, Items 8.01, 9.01, accession 0001193125-26-455762.
Written from the filing by Shamburg Markets. Figures are as reported by the company.